ALCAM and inflammatory bowel disease: In connection with this, Ma et al. also observed that CD6 and CD166 expression is increased in the inflamed mucosa of IBD patients when compared to healthy controls; furthermore, their data showed a strong correlation between CD6 expression and disease activity in IBD patients [79].